Trailing-twelve-month (TTM) revenue is $26.18 Million with a year-over-year growth of +88.11%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $9,044,581 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-19 |
| Q4 FY2025Period ended 2025-12-31 | $6,425,522 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-17 |
| Q1 FY2026Period ended 2026-03-31 | $2,368,626 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-28 |
| Q2 FY2026Period ended 2026-06-30 | $8,343,785 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-30 |
| TTM revenue | $26,182,514 |
Current P/S: $4,008,131 market capitalization ÷ $26,182,514 TTM revenue = 0.15x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:15:08.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $8.34M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:17:08.290Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Bromine | N/A | N/A | N/A | N/A | $0 | $3M |
| Bromine Segment | $2M | $3M | N/A |
$26.18M
$26.18 Million
+88.11%
vs. $13.92M a year ago (TTM)
(7.52%)
5 Year compound annual growth rate
1 Year
+88.11%
3 Year
(23.62%)
5 Year
(7.52%)
10 Year
(16.57%)
15 Year
(12.01%)
20 Year
(3.86%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $25.42M | +$17.76M | +231.79% |
| 2024 | $7.66M | ($22.38M) | (74.50%) |
| 2023 | $30.04M | ($36.05M) | (54.54%) |
| 2022 | $66.09M | +$11.06M | +20.11% |
| 2021 | $55.03M | +$26.82M | +95.10% |
| 2020 |
TTM Growth
+88.11%
3-Year CAGR
(23.62%)
5-Year CAGR
(7.52%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:17:08.290Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| N/A |
| N/A |
| N/A |
| Chemical Products | N/A | N/A | N/A | N/A | $0 | N/A |
|---|
| Chemical Products Segment | $0 | $0 | N/A | N/A | N/A | N/A |
|---|
| Corporate | N/A | N/A | N/A | N/A | $0 | N/A |
|---|
| Crude Salt | N/A | N/A | N/A | N/A | $0 | $955,000 |
|---|
| Crude Salt Segment | $154,000 | $1M | N/A | N/A | N/A | N/A |
|---|
| Natural Gas | N/A | N/A | N/A | N/A | $150,861 | N/A |
|---|
| Segment Total | N/A | N/A | N/A | N/A | $0 | N/A |
|---|
| Total Revenue | N/A | N/A | $9M | $8M | N/A | $4M |
|---|
| $28.21M |
| +$17.61M |
| +166.19% |
| 2019 | $10.60M | +$8.00M | +308.35% |
| 2018 | $2.59M | ($104.93M) | (97.59%) |
| 2017 | $107.52M | ($41.75M) | (27.97%) |
| 2016 | $149.28M | ($13.04M) | (8.03%) |
